ResMed Inc. (ASX: RMD) has reported results for first quarter of fiscal year 2020. The company has also declared an unfranked USD 0.39 per share quarterly dividend to the shareholders on records as on 7 November 2019.
- Revenues increased 17% on constant currency basis to USD 681.1 million.
- Gross margin expanded to 59.5% from 58.3%.
- New products in the mark category drove high-teens growth.
By 12:42 PM AEST, RMD was trading at $20.49, up by 10.17% relative to the last close.